NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has successfully closed the acquisition of its external manager, RP Management, LLC ("RP Management ...

On the heels of a production-tinged executive order earlier this month, the Trump administration is doubling down on efforts to boost medicine manufacturing in the U.S. | In a new public-private ...

As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look across the Atlantic for a leader deeply entrenched in the United States, by far its largest market ...

Denmark's business minister said on Friday that U.S. President Donald Trump's executive order which directs drugmakers to ...

Squeezed by insurers and middlemen, independent pharmacists such as Jolley find themselves on the front lines of a tariff ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

For the fiscal fourth quarter, adjusted earnings were 38 cents a share on revenue of $138.3 million, comfortably above ...

Novo Nordisk's CEO, who led its boom driven by obesity and diabetes medications only to see that success stall, is stepping ...

President Donald Trump put the pharmaceutical industry on notice early Monday with the signing of his "most favored nation" ...

President Trump has elevated an issue Democrats have been jawboning about for years. On Monday, the president issued an ...

President Donald Trump is right that Americans pay too high a price for many pharmaceuticals. In a May 12 speech and signing of an executive order aimed at rectifying the ...

New health data regulations promise to empower patients and help research, but can they overcome difficulties in ...